Articles de revue sur le cancer de la vessie - Derni ères parutions

InTextoResearch, agence d'information scientifique


InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer de la vessie (9 février 2008):

Apoptosis and tumor cell death in response to HAMLET (human alpha-
lactalbumin made lethal to tumor cells).
Hallgren O, Aits S, Brest P, Gustafsson L, Mossberg AK, Wullt B,
Svanborg C.
Adv Exp Med Biol. 2008;606:217-40.

Bladder cancer following upper tract urothelial carcinoma.
Kauffman EC, Raman JD.
Expert Rev Anticancer Ther. 2008 Jan;8(1):75-85.

Biological markers in the diagnosis of recurrent bladder cancer: an
overview.
Mohammed A, Khan Z, Zamora I, Bhatti A.
Expert Rev Mol Diagn. 2008 Jan;8(1):63-72.

Gemcitabine in bladder cancer.
El Karak F, Flechon A.
Expert Opin Pharmacother. 2007 Dec;8(18):3251-6.

Potential of urinary biomarkers in early bladder cancer diagnosis.
Lam T, Nabi G.
Expert Rev Anticancer Ther. 2007 Aug;7(8):1105-15.

The genetics of bladder cancer: a cytogeneticist's perspective.
Wolff DJ.
Cytogenet Genome Res. 2007;118(2-4):177-81.

Positron emission tomography and positron emission tomography/
computerized tomography of urological malignancies: an update review.
Bouchelouche K, Oehr P.
J Urol. 2008 Jan;179(1):34-45.

Guideline for the management of nonmuscle invasive bladder cancer
(stages Ta, T1, and Tis): 2007 update.
Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, Wolf
JS Jr, Schellhammer PF.
J Urol. 2007 Dec;178(6):2314-30.

Nested variant of urothelial carcinoma.
Dhall D, Al-Ahmadie H, Olgac S.
Arch Pathol Lab Med. 2007 Nov;131(11):1725-7.

Non-steroidal anti-inflammatory drugs in the treatment of
genitourinary malignancies: focus on clinical data.
Giannitsas K, Konstantinopoulos A, Perimenis P.
Expert Opin Investig Drugs. 2007 Nov;16(11):1841-9.

Experimental models for therapeutic studies of transitional cell
carcinoma.
Gabriel U, Bolenz C, Michel MS.
Anticancer Res. 2007 Sep-Oct;27(5A):3163-71.

Proteome-based diagnostics and prognosis of bladder transitional cell
carcinoma.
Wu TF, Ku WL, Tsay YG.
Expert Rev Proteomics. 2007 Oct;4(5):639-47.



(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)